- €6.34bn
- €6.41bn
- €1.19bn
- 75
- 19
- 95
- 72
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,051 | 1,078 | 1,041 | 1,341 | 1,190 |
Cost of Revenue | |||||
Gross Profit | 633 | 651 | 594 | 849 | 658 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 798 | 798 | 798 | 901 | 915 |
Operating Profit | 253 | 280 | 243 | 440 | 275 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 251 | 278 | 242 | 440 | 272 |
Provision for Income Taxes | |||||
Net Income After Taxes | 200 | 220 | 194 | 350 | 217 |
Net Income Before Extraordinary Items | |||||
Net Income | 200 | 220 | 194 | 350 | 217 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 200 | 220 | 194 | 350 | 217 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.42 | 1.57 | 1.36 | 2.49 | 1.33 |
Dividends per Share |